These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Listed as ongoing, but also has a completion date||2006-003607-40||A CONTROLLED, RANDOMISED, DOUBLE-BLIND, MULTICENTER STUDY, COMPARING METHOTREXATE VS PLACEBO IN CORTICOSTEROID-DEPENDENT ULCERATIVE COLITIS||2014-10-17||bad-data|
|Listed as ongoing, but also has a completion date||2006-005299-42||A randomized, multicenter open label study comparing cyclosporine with infliximab in steroid-refractory severe attacks of ulcerative colitis (CYSIF Study)||2013-08-28||bad-data|
|Ongoing||2009-011316-38||ESSAI MULTICENTRIQUE RANDOMISE CONTROLE, AVEC DEUX GROUPES PARALLELES, EN DOUBLE AVEUGLE, COMPARANT LE FERRISAT®AU PLACEBO DANS L’ANEMIE ASSOCIEE AUX MICI AU COURS DU TRAITEMENT PAR ANTI-TNF ALPHA||not-yet-due|
|Ongoing||2011-003038-14||A RANDOMIZED CONTROLLED TRIAL INVESTIGATING TAILORED TREATMENT WITH INFLIXIMAB FOR ACTIVE LUMINAL CROHN'S DISEASE||not-yet-due|
|Ongoing||2013-003199-11||Changing the coUrse of cRohn’s disease with an Early use of adalimumab: CURE STUDY||not-yet-due|
|Ongoing||2014-002311-41||A proSpective randomized controlled trial comParing infliximAb-antimetabolites combination therapy to anti-metabolites monotheRapy and infliximab monothErapy in Crohn’s disease patients in sustained s...||not-yet-due|
|Ongoing||2018-003490-10||An open-label randomized trial COmparing staNdard of care versus Treat to target with telemonitoRing and patient education in patients with ulcerative cOlitis initiating adalimumab : The CONTROL trial||not-yet-due|
|Ongoing||2019-001337-13||USTekinumab in fistulising Perianal Crohn’s Disease: The USTAP CD study||not-yet-due|